Sign in
4/A

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-052154

Director acquired 9,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
EASTHAM KARIN Director 2020-09-22 Grant or award +9,100 24,100 D
Derivatives
EASTHAM KARIN Director 2020-09-22 Grant or award · Stock Option +18,200 18,200 D
Loading xslF345X03/doc4a.xml…